Filter
1318
Filtered Results: 1318
Text search:
drug
susceptibility
Featured
Recommendations
161
New Publications
312
Language
Document type
No document type
717
Guidelines
230
Studies & Reports
224
Manuals
60
Strategic & Response Plan
41
Fact sheets
20
Training Material
14
Situation Updates
10
Online Courses
2
Countries / Regions
India
63
Western and Central Europe
44
Ethiopia
32
Eastern Europe
31
Kenya
30
Latin America and the Carribbean
30
South Africa
25
Global
24
Tanzania
21
Africa
20
Nepal
18
Nigeria
18
Zambia
18
Bangladesh
16
Uganda
15
Malawi
14
Philippines
14
Rwanda
12
Ghana
11
Peru
11
Zimbabwe
10
Asia
10
South–East Asia Region
10
Liberia
10
Colombia
9
Sierra Leone
9
Ukraine
8
Mozambique
8
Cambodia
8
Argentina
7
Lesotho
6
Brazil
6
Russia
6
Namibia
6
Myanmar / Burma
6
Eswatini/ Swaziland
6
Germany
5
Western Pacific Region
5
Bolivia
5
Botswana
5
Pakistan
5
Tajikistan
4
El Salvador
4
Cameroon
4
Senegal
4
Venezuela
4
Spain
4
Syria
3
Albania
3
Laos
3
Burkina Faso
3
USA
3
Congo, Democratic Republic of
3
North America
3
Uruguay
3
Lebanon
3
Vietnam
3
Sudan
3
Thailand
2
Turkey
2
Chile
2
Fiji
2
Afghanistan
2
Morocco
2
Armenia
2
Guinea-Bissau
2
Jordan
2
Saudi Arabia
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Paraguay
2
Gabon
2
United Kingdom
2
Georgia
2
Angola
2
Bhutan
2
Indonesia
2
Iraq
2
Ecuador
2
North Macedonia
1
Timor Leste/ East Timor
1
Mexico
1
Benin
1
Gambia
1
China
1
Iran
1
Qatar
1
Haiti
1
Ireland
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Portugal
1
East and Southern Africa
1
Papua New Guinea
1
Nicaragua
1
Sri Lanka
1
Greece
1
Honduras
1
Mali
1
Libya
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
414
Clinical Guidelines
167
Public Health
67
Women & Child Health
28
Key Resources
25
Pharmacy & Technologies
22
Capacity Building
17
Toolboxes
TB
382
AMR
198
HIV
101
NTDs
59
COVID-19
49
Mental Health
41
Rapid Response
40
Planetary Health
25
Pharmacy
20
Refugee
15
Ebola & Marburg
15
Global Health Education
14
Caregiver
12
NCDs
11
Polio
11
Cholera
10
Natural Hazards
8
Conflict
7
Specific Hazards
6
Malaria
5
Disability
4
Zika
3
While many of the countries hit by the COVID-19 in the first few months of the year are now beginning to relax lockdown measures as infection and death rates fall, in the regions most affected by HIV, TB and malaria, such as Africa, South Asia and Latin America, the pandemic continues to accelerate....
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
Loss and damage is an urgent concern, driven by the increasingly harmful effects of climate change. Communities are experiencing new types and forms of climate impact, of higher frequency and intensity, which they are not equipped to handle. These impacts compel vulnerable communities to migrate to ...
This short paper aims to identify key evidence gaps in our knowledge of livestock- and fisheries-linked antimicrobial resistance in the developing world, and to document on-going or planned research initiatives on this topic by key stakeholders.
The antimicrobial resistant (AMR) infections in anima...
AMR is a serious and growing global problem. A WHO report released in 2014 stated that this serious threat is no longer a prediction for the future it is happening now in every region of the world and has potential to affect anyone, of any age in any community – a real threat to the public health....
Advances have been made through expanded interventions delivered through five public health approaches: innovative and intensified disease management; preventive chemotherapy; vector ecology and management; veterinary public health services; and the provision of safe water, sanitation and hygiene. I...
Pharmaceuticals 2024, 17(6), 691; https://doi.org/10.3390/ph17060691
Published: 5 January 2010 Received: 30 January 2009
BMC Neurology 2010, 10:1 doi:10.1186/1471-2377-10-1
This article is available from: http://www.biomedcentral.com/1471-2377/10/1
Module 5
Monitoring and Evaluation
October 2018
Module 5: Monitoring and evaluation. This module is for people responsible for monitoring PrEP programmes at the national and site levels. It provides information on how to monitor PrEP for safety and effectiveness, suggesting core and additiona...
Buruli ulcer (BU), a neglected tropical disease (NTD), is an infection of the skin and subcutaneous tissue caused by Mycobacterium ulcerans. The disease has been documented in many South American, Asian, and Western Pacific countries and is widespread throughout much of Africa, especially in West...
STAATSKOERANT, 5 MEI 2015 No. 38763
No. 38763 GOVERNMENT GAZETTE, 5 MAY 2015
General Notice
Notice 295 of 2015
Department of basic education
National education policy act, 1996 (Act No 27 of 1996)
Call for written submissions from stakeholder bodies and members of the public on Departmen...
Guidance Document and supporting Resources
Frontiers in Pediatrics | www.frontiersin.org
1 April 2019 | Volume 7 | Article 159
